Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, and skin and soft‑tissue infections, and is used in adults and children as directed by a healthcare professional.

GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable supply chain management across diverse markets.

Clarithromycin is indicated for several bacterial infections affecting the respiratory and skin systems.

- Community‑acquired pneumonia: eradicates the causative bacteria and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft‑tissue infections: treats cellulitis, erysipelas, and other bacterial skin conditions. - Helicobacter pylori eradication: used in combination therapy to eliminate H. pylori infection.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Altered taste: metallic or bitter sensation.

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis: severe diarrhea requiring medical attention. - Hepatic enzyme elevation: potential liver function abnormalities. - Severe hypersensitivity reactions: including anaphylaxis, rash, or Stevens‑Johnson syndrome.

Before prescribing clarithromycin, clinicians should consider several safety factors.

- Assess renal function: adjust dose in severe impairment. - Monitor liver enzymes: use with caution in hepatic disease. - Avoid in known macrolide allergy: discontinue if reaction occurs. - Consider QT interval: avoid in patients with prolonged QT or on other QT‑prolonging drugs. - Pregnancy and breastfeeding: use only if benefits outweigh risks. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Clarithromycin interacts with several medications; careful management is required.

Major Interactions (Avoid): - Statins (simvastatin, lovastatin): increased risk of rhabdomyolysis. - Ergot alkaloids: risk of ergotism. - Pimozide: heightened risk of arrhythmia.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - Theophylline: may raise plasma concentrations. - Carbamazepine: may reduce clarithromycin levels, decreasing efficacy.